IL1B and abscess: Previously, we demonstrated that auranofin applied topically is effective in significantly reducing the burden of MRSA in an uncomplicated abscess model in mice and in decreasing expression of pro-inflammatory cytokines (TNF-α, MCP-1, IL-1β, and IL-6) that may impair wound healing14.